COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 52: Articles 511-520  | Next

Adherence to Public Health Recommendations, Restrictions, and Requirements among Priority Populations at Risk for COVID-19 Mortality and Infection in Australia
Narayanasamy, S., Altermatt, A., Wilkinson, A. L., Heath, K., Gibney, K., Hellard, M., Pedrana, A.
10.64898/2026.02.15.26346356 — Posted: 2026-02-17
Electroconvulsive Therapy during the COVID-19 Pandemic: Nationwide Data from Denmark
Reinecke-Tellefsen, C. J., Orberg, A., Ostergaard, S. D.
10.64898/2026.02.13.26346228 — Posted: 2026-02-17
Disruption and recovery of notifiable infectious diseases after COVID-19 in Australia, 2015-2025
Farquhar, H. L.
10.64898/2026.02.13.26346301 — Posted: 2026-02-17
Peak alpha frequency is associated with pain severity in Long COVID patients with new-onset chronic pain
Silva-Passadouro, B., Khoja, O., Casson, A. J., Delis, I., Brown, C., Sivan, M.
10.64898/2026.02.16.26346388 — Posted: 2026-02-17
A Case Report Describing a Persistent SARS-CoV-2 Infection Outcomes and Mutations Associated with B-cell Deficiency
Mohamed, R., Shipe, A., Lail, A., Emmen, I. E., Vuyk, W., Minor, N. R., Bradley, T., Gifford, A., Wilson, N. A., O'Connor, D., Garonzik Wang, J., Smith, J.
10.64898/2026.02.13.26346281 — Posted: 2026-02-17
Antibody Responses Against Coronaviruses in the Wuhan Population
Zhou, S., Liu, C., Liu, W., Cai, K., Lan, K., Zhu, C., Wang, Q., Liu, L.
10.64898/2026.02.15.705976 — Posted: 2026-02-17
Cross-reactivity of SARS-CoV-2-specific T cells against tumor-associated antigens via molecular mimicry
Ragone, C., Mauriello, A., Cavalluzzo, B., Mangano, S., Cembrola, B., Ciotola, N., Tagliamonte, M., Buonaguro, L.
10.64898/2026.02.16.706083 — Posted: 2026-02-17
It is not just about the science - the impact of undergraduate research projects and COVID-19 on graduate attributes and employability.
Kyriazi, M., Jung, J. F., Wilkinson, S., Brown, A., Panti, K., Armstrong, V. L.
10.64898/2026.02.13.705786 — Posted: 2026-02-16
COVID-19 hospitalizations in the Netherlands, 2023-2024: disease burden and vaccine effectiveness
de Gier, B., Smagge, B., van Roon, A., Veldhuijzen, I., de Boer, P., Knol, M., Hahne, S., de Melker, H.
10.64898/2026.02.12.26346177 — Posted: 2026-02-16
Sickness presenteeism due to respiratory infection in the English workforce: prevalence estimates and demographic factors from the Winter COVID-19 Infection Study (WCIS)
Burdon, M. G., Denson, S., Tang, M., Mellor, J., Ward, T.
10.64898/2026.02.13.26346245 — Posted: 2026-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).